NMO Spectrum Disorder: Clinical Trials

1 trial for NMO Spectrum Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow NMO Spectrum Disorder: new trials by email Literature Review of NMO Spectrum Disorder trials Research Report on NMO Spectrum Disorder

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders
Belimumab - NMO Spectrum Disorder
Phase 1 / Phase 2CompletedTianjin Medical University General Hospital142021-12-122024-10-16

Narrower conditions

Neuromyelitis Optica (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Cranial Nerve Diseases (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Eye Diseases (1)  ·  Immune System Diseases (1)  ·  Myelitis, Transverse (1)  ·  Nervous System Diseases (1)  ·  Optic Nerve Diseases (1)  ·  Optic Neuritis (1)

Interventions

belimumab (1)

Sponsors

Tianjin Medical University General Hospital (1)

Countries

China (1)